A recent study shows that three CSF markers, MBP, NFL and GFAp, can measure ongoing damage of oligodendrocytes, axons and astrocytes in patients with MS. This capability can be used to improve current methods of evaluating disease activity.

https://onlinelibrary.wiley.com/doi/10.1111/ane.12239/abstract;jsessionid=0BC1364DCBA7F0E3E8C0754031C4D61F.f03t04